Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | -2.13% | -81.65% | -87.30% |
Apr. 17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
Apr. 16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.30% | 77.44M | |
+24.61% | 672B | |
+24.08% | 550B | |
-5.55% | 351B | |
+15.40% | 317B | |
+7.42% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.76% | 144B | |
-6.64% | 141B |
- Stock Market
- Equities
- MRNS Stock
- News Marinus Pharmaceuticals, Inc.
- Marinus Pharmaceuticals : Truist Securities Adjusts Marinus Pharmaceuticals' Price Target to $40 From $35, Maintains Buy Rating